News Advisory
Genome-wide Association Studies for Cancer: NCI Science Writers Seminar
|
| What: |
Please join us for a special science writers seminar to discuss genome-wide association studies (GWAS) in cancer research. This promising technology enables researchers to identify novel regions of the genome associated with susceptibility to cancer by using common single nucleotide polymorphisms (SNPs). Leading experts in the field will discuss how to identify important studies, the mechanisms involved in GWAS research, and the promise of GWAS for future cancer research. The seminar will allow ample time for Q&A and interaction with National Cancer Institute (NCI) scientists. A tour of NCI’s Core Genotyping Facility will wrap up the morning discussion. |
| Who: |
Experts from the Division of Cancer
Epidemiology and Genetics, NCI, including:
- Stephen Chanock, M.D., chief, Laboratory of Translational Genomics
- Neil Caporaso, M.D., chief, Pharmacogenetics Section, Genetic Epidemiology
- Patricia Hartge, Sc.D., deputy director, Epidemiology and Biostatistics
- Sholom Wacholder, Ph.D., senior investigator, Biostatistics Branch
- Laufey Amundadottir, Ph.D., investigator, Lab of Translational Genomics
|
| When: |
Thursday, March 19, 2009: 9:00
a.m. – Noon
(EDT)
Registration will be at 8:45 a.m. Talks by experts will
begin at 9:00 a.m. Coffee and light refreshments will be
available at the start of the seminar |
| Where: |
NCI’s Core Genotyping Facility
8717 Grovemont Circle, Gaithersburg, Maryland
Using public transportation, the facility is accessible via Ride-On buses 61 and 43 from the Shady Grove station at the end of Metro's red line. Please consult www.WMATA.com for further details. Limited parking is available on site. For directions and more information on the facility, please go to http://cgf.nci.nih.gov/resources/location.html |
| How: |
Please register for the seminar by contacting the NCI Office of Media Relations at (301) 496-6641 or ncipressofficers@mail.nih.gov. Space is limited |
NCI leads the National Cancer Program and the NIH effort to dramatically reduce the burden of cancer and improve the lives of cancer patients and their families, through research into prevention and cancer biology, the development of new interventions, and the training and mentoring of new researchers. For more information about cancer, please visit the NCI Web site at http://www.cancer.gov or call NCI's Cancer Information Service at 1-800-4-CANCER (1-800-422-6237).
The National Institutes of Health (NIH) — The Nation's
Medical Research Agency — includes 27 Institutes and
Centers and is a component of the U.S. Department of Health and
Human Services. It is the primary federal agency for conducting
and supporting basic, clinical and translational medical research,
and it investigates the causes, treatments, and cures for both
common and rare diseases. For more information about NIH and
its programs, visit www.nih.gov. |
